“Assessment of Dapagliflozin Effectiveness As Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus ”. Academia Journal of Medicine, vol. 4, no. 2, Dec. 2021, pp. 50-54, https://doi.org/10.48165/3e51d373.